MedWire News: Screening asymptomatic individuals for subclinical atherosclerosis has the potential to improve cardiovascular disease (CVD) prevention strategies, but any screening program must yet be proven to prevent actual cardiovascular disease, an editorial viewpoint and commentary suggest.
